Opening Keynotes, • 9/22/25 Opening Keynote: The Evolving Regulatory Environment for Rare Disease Trials Previous Opening Keynote: The Future of Rare Disease Trials You Might Also Like How to Accelerate the Adoption of Decentralized Trials for Rare Disease Indications Decentralized by Design: Operationalizing Hybrid Rare Disease Trials Adaptive & Precision-Driven Trials: Platform and MATCH Models for Rare Disease Breakthroughs Leveraging Patient Advocacy To Scale Rare Disease Trials Beyond Biotech: The Rise of Nontraditional Sponsors in Rare Disease Trials
Opening Keynotes, • 9/22/25 Opening Keynote: The Evolving Regulatory Environment for Rare Disease Trials Previous Opening Keynote: The Future of Rare Disease Trials You Might Also Like How to Accelerate the Adoption of Decentralized Trials for Rare Disease Indications Decentralized by Design: Operationalizing Hybrid Rare Disease Trials Adaptive & Precision-Driven Trials: Platform and MATCH Models for Rare Disease Breakthroughs Leveraging Patient Advocacy To Scale Rare Disease Trials Beyond Biotech: The Rise of Nontraditional Sponsors in Rare Disease Trials
